Botulinum toxin for treatment of glandular hypersecretory disorders

Journal of Plastic, Reconstructive and Aesthetic Surgery

Volumn 61, Issue 9, 2008, Pages 1024-1028

  Laing, T A ^a   Laing, M E ^b   O'Sullivan, S T ^a  

^a Department of Medicine National University of Ireland Cork   (Ireland)

^b WATERFORD REGIONAL HOSPITAL   (Ireland)

Author keywords

Botulinum toxin; Epiphora; Frey's syndrome; Glandular hypersecretory disorders; Hyperhidrosis; Sialorrhoea

Indexed keywords

BOTULINUM TOXIN;

CHRONIC RHINITIS; DRUG EFFICACY; EPIPHORA; FREY SYNDROME; HUMAN; HYPERHIDROSIS; HYPERSALIVATION; LACRIMATION DISORDER; PAROTIDECTOMY; PRIORITY JOURNAL; REVIEW; RHINORRHEA; SALIVARY GLAND DISEASE;

ADOLESCENT; AGED; AGED, 80 AND OVER; BOTULINUM TOXINS, TYPE A; FEMALE; HUMANS; HYPERHIDROSIS; INFANT; LACRIMAL APPARATUS DISEASES; MALE; MIDDLE AGED; NEUROTOXINS; RHINITIS, VASOMOTOR; SALIVARY GLAND DISEASES; SIALADENITIS; SIALORRHEA; SWEAT GLAND DISEASES; SWEATING, GUSTATORY; TREATMENT OUTCOME;

EID: 50349090674     PISSN: 17486815     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjps.2008.03.023     Document Type: Review

References (35)

1. Erbguth F.J. Historical notes on botulism, Clostridium botulinum, botulinum toxin, and the idea of the therapeutic use of the toxin. Mov Disord 19 (2004) S2-S6
2. Munchau A., and Bhatia K.P. Uses of botulinum toxin injection in medicine today. BMJ 320 (2000 Jan 15) 161-165
3. Naumann M., Zellner M., Toyka K.V., et al. Treatment of gustatory sweating with botulinum toxin. Ann Neurol 42 (1997 Dec) 973-975
4. Montoya F.J., Riddell C.E., Caesar R., et al. Treatment of gustatory hyperlacrimation (crocodile tears) with injection of botulinum toxin into the lacrimal gland. Eye 16 (2002 Nov) 705-709
5. Shelley W.B., Talanin N.Y., and Shelley E.D. Botulinum toxin therapy for palmar hyperhidrosis. J Am Acad Dermatol 38 (1998 Feb) 227-229
6. Saadia D., Voustianiouk A., Wang A.K., et al. Botulinum toxin type A in primary palmar hyperhidrosis: randomized, single-blind, two-dose study. Neurology 57 (2001 Dec 11) 2095-2099
7. Heckmann M., Ceballos-Baumann A.O., Plewig G., et al. Botulinum toxin A for axillary hyperhidrosis (excessive sweating). N Engl J Med 344 (2001 Feb 15) 488-493
8. Heckmann M., Plewig G., and Hyperhidrosis Study Group. Low-dose efficacy of botulinum toxin A for axillary hyperhidrosis: a randomized, side-by-side, open-label study. Arch Dermatol 141 (2005 Oct) 1255-1259
9. Baumann L., Slezinger A., Halem M., et al. Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis. Int J Dermatol 44 (2005 May) 418-424
10. Glogau R.G. Topically applied botulinum toxin type A for the treatment of primary axillary hyperhidrosis: results of a randomized, blinded, vehicle-controlled study. Dermatol Surg 33 (2007 Jan) S76-S80
11. Talarico-Filho S., Mendonca DO Nascimento M., Sperandeo DE Macedo F., et al. A double-blind, randomized, comparative study of two type A botulinum toxins in the treatment of primary axillary hyperhidrosis. Dermatol Surg 33 (2007 Jan) S44-S50
12. Naumann M., Hofmann U., Bergmann I., et al. Focal hyperhidrosis. Effective treatment with intracutaneous botulinum toxin. Arch Dermatol 134 (1998) 1298-1299
13. Dulguerov P., Marchal F., and Gysin C. The bullet that hit a nerve: the history of Lucja Frey and her syndrome. J Laryngol Otol 120 (2006 Dec) 1087
14. Laage-Hellman J.E. Gustatory sweating and flushing after conservative parotidectomy. Acta Otolaryngol 48 (1957 Sep) 234-252
15. Smith Jr. R.O., Hemenway W.G., Stevens K.M., et al. Jacobson's neurectomy for Frey's syndrome. Am J Surg 120 (1970 Oct) 478-481
16. Debets J., and Munting J. Parotidectomy for parotid tumours: 19-year experience from the Netherlands. Br J Surg 79 (1992 Nov) 1159-1161
17. Sinha U.K., Saadat D., Doherty C.M., et al. Use of AlloDerm implant to prevent Frey syndrome after parotidectomy. Arch Facial Plast Surg 5 (2003 Jan-Feb) 109-112
18. Blumenfeld R.J., and Friedman J.E. Intratympanic surgical treatment of Frey's syndrome. Arch Otolaryngol 86 (1967 Jul) 2-7
19. Eckardt A., and Kuettner C. Treatment of gustatory sweating (Frey's syndrome) with botulinum toxin A. Head Neck 25 (2003 Aug) 624-628
20. Tugnoli V., Marchese Ragona R., Eleopra R., et al. The role of gustatory flushing in Frey's syndrome and its treatment with botulinum toxin type A. Clin Auton Res 12 (2002 Jun) 174-178
21. Guntinas-Lichius O. Increased botulinum toxin type A dosage is more effective in patients with Frey's syndrome. Laryngoscope 112 (2002 Apr) 746-749
22. Luna Ortiz K., Rascon Ortiz M., Sansón Riofrio J.A., et al. Control of Frey's syndrome in patients treated with botulinum toxin type A. Med Oral Patol Oral Cir Bucal 12 (2007 Jan 1) E79-E84
23. Wang C.C., and Wang C.P. Preliminary experience with botulinum toxin type A intracutaneous injection for Frey's syndrome. J Chin Med Assoc 68 (2005 Oct) 463-467
24. Banerjee K.J., Glasson C., and O'Flaherty S.J. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy. Dev Med Child Neurol 48 (2006 Nov) 883-887
25. Su C.S., Lan M.Y., Liu J.S., et al. Botulinum toxin type A treatment for Parkinsonian patients with moderate to severe sialorrhea. Acta Neurol Taiwan 15 (2006 Sep) 170-176
26. Verma A., and Steele J. Botulinum toxin improves sialorrhea and quality of living in bulbar amyotrophic lateral sclerosis. Muscle Nerve 34 (2006 Aug) 235-237
27. Nava-Castaneda A., Tovilla-Canales J.L., Boullosa V., et al. Duration of botulinum toxin effect in the treatment of crocodile tears. Ophthal Plast Reconstr Surg 22 (2006 Nov-Dec) 453-456
28. Whittaker K.W., Matthews B.N., Fitt A.W., et al. The use of botulinum toxin A in the treatment of functional epiphora. Orbit 22 (2003 Sep) 193-198
29. Rohrbach S., Olthoff A., Laskawi R., et al. Botulinum toxin type A induces apoptosis in nasal glands of guinea pigs. Ann Otol Rhinol Laryngol 110 (2001 Nov) 1045-1050
30. Ozcan C., Vayisoglu Y., Dogu O., et al. The effect of intranasal injection of botulinum toxin A on the symptoms of vasomotor rhinitis. Am J Otolaryngol 27 (2006 Sep-Oct) 314-318
31. Unal M., Sevim S., Dogu O., et al. Effect of botulinum toxin type A on nasal symptoms in patients with allergic rhinitis: a double-blind, placebo-controlled clinical trial. Acta Otolaryngol 123 (2003 Dec) 1060-1063
32. Shaari C.M., Sanders I., Wu B.L., et al. Rhinorrhea is decreased in dogs after nasal application of botulinum toxin. Otolaryngol Head Neck Surg 112 (1995 Apr) 566-571
33. Rohrbach S., and Laskawi R. Minimally invasive application of botulinum toxin type A in nasal hypersecretion. ORL J Otorhinolaryngol Relat Spec 63 (2001 Nov-Dec) 382-384
34. Ellies M., Gottstein U., Rohrbach-Volland S., et al. Reduction of salivary flow with botulinum toxin: extended report on 33 patients with drooling, salivary fistulas, and sialadenitis. Laryngoscope 114 (2004 Oct) 1856-1860
35. Guntinas-Lichius O., and Jungehulsing M. Treatment of chronic parotid sialectasis with botulinum toxin A. Laryngoscope 112 (2002 Mar) 586-587